BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 8060152)

  • 1. [Interleukin-6].
    Nishimoto N; Ogata A; Shima Y; Yoshizaki K
    Gan To Kagaku Ryoho; 1994 Aug; 21(10):1707-16. PubMed ID: 8060152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Signal transduction through gp130 that is shared among the receptors for the interleukin 6 related cytokine subfamily.
    Hirano T; Matsuda T; Nakajima K
    Stem Cells; 1994 May; 12(3):262-77. PubMed ID: 8075593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth regulatory pathways in myeloma. Evidence for autocrine oncostatin M expression.
    Westendorf JJ; Jelinek DF
    J Immunol; 1996 Oct; 157(7):3081-8. PubMed ID: 8816418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Advances in interleukin-6 therapy].
    Ogata A; Nishimoto N; Yoshizaki K
    Rinsho Byori; 1999 Apr; 47(4):321-6. PubMed ID: 10340005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. gp130 and the IL-6 family of cytokines: signaling mechanisms and thrombopoietic activities.
    Nakashima K; Taga T
    Semin Hematol; 1998 Jul; 35(3):210-21. PubMed ID: 9685167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-6 signal transduction and its physiological roles: the signal orchestration model.
    Kamimura D; Ishihara K; Hirano T
    Rev Physiol Biochem Pharmacol; 2003; 149():1-38. PubMed ID: 12687404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Principles of interleukin (IL)-6-type cytokine signalling and its regulation.
    Heinrich PC; Behrmann I; Haan S; Hermanns HM; Müller-Newen G; Schaper F
    Biochem J; 2003 Aug; 374(Pt 1):1-20. PubMed ID: 12773095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The evidence for interleukin-6 as an autocrine growth factor in malignancy.
    Akira S; Kishimoto T
    Semin Cancer Biol; 1992 Feb; 3(1):17-26. PubMed ID: 1643291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropoietin, a new IL-6-related cytokine signaling through the ciliary neurotrophic factor receptor.
    Derouet D; Rousseau F; Alfonsi F; Froger J; Hermann J; Barbier F; Perret D; Diveu C; Guillet C; Preisser L; Dumont A; Barbado M; Morel A; deLapeyrière O; Gascan H; Chevalier S
    Proc Natl Acad Sci U S A; 2004 Apr; 101(14):4827-32. PubMed ID: 15051883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physician Education: The Erythropoietin Receptor and Signal Transduction.
    Yoshimura A; Arai K
    Oncologist; 1996; 1(5):337-339. PubMed ID: 10388012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of oligodendrocyte cell survival and differentiation by ciliary neurotrophic factor, leukemia inhibitory factor, oncostatin M, and interleukin-6.
    Vos JP; Gard AL; Pfeiffer SE
    Perspect Dev Neurobiol; 1996; 4(1):39-52. PubMed ID: 9169918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The biology of interleukin 11.
    Neben S; Turner K
    Stem Cells; 1993 Jul; 11 Suppl 2():156-62. PubMed ID: 8401258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A ciliary neurotrophic factor-sensitive human myeloma cell line.
    Gu ZJ; Zhang XG; Hallet MM; Lu ZY; Wijdenes J; Rossi JF; Klein B
    Exp Hematol; 1996 Aug; 24(10):1195-200. PubMed ID: 8765494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired immune and acute-phase responses in interleukin-6-deficient mice.
    Kopf M; Baumann H; Freer G; Freudenberg M; Lamers M; Kishimoto T; Zinkernagel R; Bluethmann H; Köhler G
    Nature; 1994 Mar; 368(6469):339-42. PubMed ID: 8127368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complex conserved organization of the mammalian leukemia inhibitory factor gene: regulated expression of intracellular and extracellular cytokines.
    Haines BP; Voyle RB; Pelton TA; Forrest R; Rathjen PD
    J Immunol; 1999 Apr; 162(8):4637-46. PubMed ID: 10202003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of the signal transducer glycoprotein 130 by both IL-6 and IL-11 requires two distinct binding epitopes.
    Kurth I; Horsten U; Pflanz S; Dahmen H; Küster A; Grötzinger J; Heinrich PC; Müller-Newen G
    J Immunol; 1999 Feb; 162(3):1480-7. PubMed ID: 9973404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin 6: from bench to bedside.
    Nishimoto N; Kishimoto T
    Nat Clin Pract Rheumatol; 2006 Nov; 2(11):619-26. PubMed ID: 17075601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ambivalent aspects of interleukin-6 in cerebral ischemia: inflammatory versus neurotrophic aspects.
    Suzuki S; Tanaka K; Suzuki N
    J Cereb Blood Flow Metab; 2009 Mar; 29(3):464-79. PubMed ID: 19018268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-6 and related cytokines: effect on the acute phase reaction.
    Heinrich PC; Horn F; Graeve L; Dittrich E; Kerr I; Müller-Newen G; Grötzinger J; Wollmer A
    Z Ernahrungswiss; 1998; 37 Suppl 1():43-9. PubMed ID: 9558728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-6 and oncostatin M stimulation of proliferation of prostate cancer 22Rv1 cells through the signaling pathways of p38 mitogen-activated protein kinase and phosphatidylinositol 3-kinase.
    Godoy-Tundidor S; Cavarretta IT; Fuchs D; Fiechtl M; Steiner H; Friedbichler K; Bartsch G; Hobisch A; Culig Z
    Prostate; 2005 Jul; 64(2):209-16. PubMed ID: 15712220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.